Home » Authors » Tom Wall

Articles by Tom Wall

Tranzyme Jumps into IPO Queue, Files for $75M Offering

Nov. 24, 2010

Regeneron Stock Up 19.7% After Positive VEGF Trap-Eye Report

Nov. 23, 2010

The talk from Regeneron Pharmaceuticals Inc. is of trials – clinical and, perhaps, legal. (BioWorld Today)

Archemix Could Get $315M in Baxter Hemophilia Assets Deal

Nov. 22, 2010

Sekisui Buys Genzyme's Diagnostic Unit for $265M

Nov. 19, 2010

It was biotech's version of "buy-one-get-one" for Genzyme business units on Thursday. (BioWorld Today)

Forma Will Get $20M from Eisai in Drug Discovery Deal

Nov. 18, 2010

Aires Gives Novartis $250M Option, Gets $20M Series B

Nov. 15, 2010

Micromet Shares Dip $1 After Pricing $72M Offering

Nov. 12, 2010

Agenta's Proteoglycan Delivery Technology Regenerates Bone

Nov. 11, 2010

LFB Biotechnologies to Take GTC Biotherapeutics Private

Nov. 9, 2010

Karyopharm's $20M Series A Will Finance SINE Candidates

Nov. 4, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...